10.03.2013 • News

Singapore's Temasek to Buy Stake in Germany's Evonik

Singapore state investor Temasek Holdings will take a stake in Evonik Industries, two sources close to one of the German company's owners told Reuters.

Temasek will spend more than €600 million ($779 million) for 5% of the Essen-based chemicals company, which is preparing for a stock market share listing, the sources said on condition that they not be identified.

German magazine Wirtschaftswoche reported on Saturday that Temasek and Evonik had agreed the sale.

A spokesman for Temasek declined to confirm the deal.

The RAG trust, which owns 75% of Evonik, and buyout firm CVC Capital Partners, owner of the rest, said last month that they had placed a small stake with institutional investors as a prelude to an initial public offering (IPO).

Sources close to the matter said that the listing could value the company at €14 billion. Stock market trading of Evonik shares is planned for late April.

Evonik, RAG and CVC all declined to comment on whether a sale to Temasek had been agreed.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

most read